Shorter weaning from ventilator with levosimendan
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests if a heart medication called levosimendan helps people get off the breathing machine (ventilator) faster. It's for people who have been on a ventilator for more than 48 hours and have already tried and failed to breathe on their own.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You've been on a breathing machine for more than 2 days (48 hours).
- You've tried to breathe on your own but couldn't (failed a spontaneous breathing trial).
- You are 18 years or older.
- If you're a woman under 60, you'll need a negative pregnancy test before starting.
- You cannot have certain heart, kidney, or liver conditions that would make the study drug unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
If you are on a breathing machine in the ICU and ready to try breathing on your own, this study looks at how much oxygen your body uses during that test. It may help doctors better understand when you are ready to come off the ventilator.
This study looks at people who have a tracheostomy and have been on a breathing machine for at least two weeks. Researchers want to see if certain lung measurements can help predict how easy or hard it will be to come off the ventilator.
This study looks at how breathing machine settings and monitoring can help predict if a patient will successfully come off the ventilator. It may help doctors choose better settings for patients who are ready to try breathing on their own.
This trial is studying why some people have trouble coming off a breathing machine (ventilator). It's for patients who've been on a ventilator for at least 2 days and don't have certain other conditions.
This trial tests a medication called levosimendan to help people with severe heart failure who are still very short of breath even after standard treatment. The goal is to see if it can improve symptoms and help you feel better.
This study tests whether giving levosimendan early (a heart-strengthening medicine) improves outcomes compared with placebo, on top of standard inotropic support, in people with cardiogenic shock. It mainly looks at whether patients have fewer serious complications or deaths.
Hear when a new Mechanical Ventilation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.